Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

CD44

  • You have access
    SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma
    PIOTR CIERPIKOWSKI, ANNA LIS-NAWARA and JULIA BAR
    Anticancer Research November 2021, 41 (11) 5405-5413; DOI: https://doi.org/10.21873/anticanres.15352
  • You have access
    CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma
    YOHEI SEKINO, KENSHIRO TAKEMOTO, DAIKI MURATA, TAKASHI BABASAKI, KOHEI KOBATAKE, HIROYUKI KITANO, KENICHIRO IKEDA, KEISUKE GOTO, SHOGO INOUE, TETSUTARO HAYASHI, DAIKI TANIYAMA, MASANOBU SHIGETA, KAZUYA KURAOKA, KOJI MITA, MAYUMI KANEKO, KAZUHIRO SENTANI, NAOHIDE OUE and JUN TEISHIMA
    Anticancer Research October 2021, 41 (10) 4875-4883; DOI: https://doi.org/10.21873/anticanres.15301
  • You have access
    Distribution and Expression of the Adhesion Molecule CD44 on Human Corneal Grafts Is Not Altered by Chemotherapy
    GEORGIOS S. DIMTSAS, XANTHIPPI GRAMMATOGLOU, THEODOSIA CHOREFTAKI, MARIA DETTORAKI, AIKATERI KARATHANOU, NIKOLAOS GOULIOPOULOS, CHRISTOS DAMASKOS and MARILITA M. MOSCHOS
    Anticancer Research December 2020, 40 (12) 6885-6889; DOI: https://doi.org/10.21873/anticanres.14711
  • You have access
    Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression
    SAWAKO MIYOSHI, HITOSHI TSUGAWA, JUNTARO MATSUZAKI, KENRO HIRATA, HIDEKI MORI, HIDEYUKI SAYA, TAKANORI KANAI and HIDEKAZU SUZUKI
    Anticancer Research November 2018, 38 (11) 6163-6170; DOI: https://doi.org/10.21873/anticanres.12969
  • You have access
    Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma
    HIROKO MATUURA, MORIKAZU MIYAMOTO, MASASHI TAKANO, HIROAKI SOYAMA, TADASHI AOYAMA, TOMOYUKI YOSHIKAWA, KENTO KATO, TAKAHIRO SAKAMOTO, MIKA KUWAHARA, KAZUKI TAKASAKI, HIROKI ISHIBASHI, HIDEKI IWAHASHI, HITOSHI TSUDA and KENICHI FURUYA
    Anticancer Research February 2018, 38 (2) 717-722;
  • You have access
    Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma
    ANDERS NÄSMAN, CINZIA BERSANI, DAVID LINDQUIST, JUAN DU, TORBJÖRN RAMQVIST and TINA DALIANIS
    Anticancer Research October 2017, 37 (10) 5319-5328;
  • You have access
    Expression of Cancer Stem Cell-associated DKK1 mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma
    TOMOHIKO SAKABE, JUNYA AZUMI, YOSHIHISA UMEKITA, KAN TORIGUCHI, ETSURO HATANO, YASUAKI HIROOKA and GOSHI SHIOTA
    Anticancer Research September 2017, 37 (9) 4881-4888;
  • You have access
    Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer
    ARNAUD DA CRUZ PAULA and CARLOS LOPES
    Anticancer Research May 2017, 37 (5) 2173-2183;
  • You have access
    Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients
    MICHAEL STOTZ, SEREINA A. HERZOG, MARTIN PICHLER, MARIA SMOLLE, JAKOB RIEDL, CHRISTOPHER ROSSMANN, ANGELIKA BEZAN, HERBERT STÖGER, WILFRIED RENNER, ANDREA BERGHOLD and ARMIN GERGER
    Anticancer Research April 2017, 37 (4) 2011-2018;
  • You have access
    Characterization of CD44+ALDH1+Ki-67− Cells in Non-malignant and Neoplastic Lesions of the Breast
    ARNAUD DA CRUZ PAULA, ORIANA MARQUES, RITA SAMPAIO, ANA ROSA, JOSÉ GARCIA, ALEXANDRA RÊMA, MARIA DE FÁTIMA FARIA, PAULA SILVA, RAMÓN VIZCAÍNO and CARLOS LOPES
    Anticancer Research September 2016, 36 (9) 4629-4638;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire